{
  "hypothesis": "h307 - Lidocaine-Specific Boosting Analysis",
  "date": "2026-02-05",
  "findings": {
    "lidocaine_gt_diseases": 125,
    "lidocaine_predictions": 165,
    "lidocaine_precision_exact": 13.3,
    "lidocaine_precision_fuzzy": 26.7,
    "key_insight": "Lidocaine alone = 2.1% precision, with Bupivacaine = 17.9%"
  },
  "generalized_finding": {
    "rule": "Drug predicted ALONE (no classmates from same therapeutic class) has much lower precision than with classmates",
    "affected_classes": {
      "local_anesthetics": {
        "alone": 1.8,
        "with_classmates": 15.0,
        "diff": 13.2
      },
      "corticosteroids": {
        "alone": 0.0,
        "with_classmates": 12.6,
        "diff": 12.6
      },
      "tnf_inhibitors": {
        "alone": 3.4,
        "with_classmates": 27.3,
        "diff": 23.8
      },
      "nsaids": {
        "alone": 2.4,
        "with_classmates": 7.1,
        "diff": 4.7
      }
    },
    "exception": "statins - alone is BETTER (37.5% vs 29.3%)"
  },
  "implementation_impact": {
    "predictions_demoted": 212,
    "hits_lost": 4,
    "demoted_precision": 1.9,
    "by_tier": {
      "HIGH": {
        "total": 36,
        "hits": 0,
        "precision": 0.0
      },
      "MEDIUM": {
        "total": 116,
        "hits": 4,
        "precision": 3.4
      },
      "LOW": {
        "total": 60,
        "hits": 0,
        "precision": 0.0
      }
    }
  },
  "conclusion": "Lidocaine-specific boosting NOT warranted. Instead, BROAD CLASS ISOLATION DEMOTION is warranted: drugs from broad therapeutic classes (anesthetics, steroids, TNFi, NSAIDs) predicted alone should be demoted due to 1.9% precision.",
  "action": "Add BROAD_CLASS_ISOLATION_DEMOTION rule to production_predictor.py"
}